XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Statement [Abstract]        
Research and development expenses $ 3,589 $ 627 $ 5,737 $ 1,269
Marketing expenses 100 170
General and administrative expenses 802 552 1,535 1,194
Total operating expenses 4,491 1,179 7,442 2,463
Operating loss 4,491 1,179 7,442 2,463
Finance income, net (2) (3) (26) (1)
Net Loss 4,489 1,176 7,416 2,462
Other comprehensive income:        
Foreign currency translation adjustment (6) (6) (11)
Comprehensive loss for the period $ 4,489 $ 1,170 $ 7,410 $ 2,451
Basic net loss per common stock $ 0.82 $ 0.27 $ 1.42 $ 0.66
Diluted net loss per common stock $ 0.82 $ 0.27 $ 1.42 $ 0.66
Weighted average number of common stock outstanding used in computing basic net loss per share 5,475,748 4,312,294 5,234,765 3,706,510
Weighted average number of common stock outstanding used in computing diluted net loss per share 5,475,748 4,312,294 5,234,765 3,706,510